Long-Term Benefits of the Spiration® Valve System in Emphysema Patients: 5-Year Results from the EMPROVE Trial

被引：0

作者：

Criner, G. J. ^{[1
]}

Reed, M. ^{[2
]}

Abu-Hijleh, M. ^{[3
]}

Majid, A. ^{[4
]}

机构：

[1] Temple Univ Hosp & Med Sch, Pulm & Crit Care Med, Philadelphia, PA USA

[2] Penn State Hlth, Pulm & Crit Care Med, Hershey, PA USA

[3] UT SouthWestern Med Ctr Dallas, Div Pulm Crit Care & Sleep Med, Dallas, TX USA

[4] Beth Israel Deaconess Med Ctr, Boston, MA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4560

引用

页数：2

共 50 条

[41] Clinical benefits of donepezil: Results from a long-term phase III extension trial
Doody, RS
Pratt, RD
Perdomo, CA
NEUROLOGY, 1999, 52 (06) : A174 - A174
[42] LONG-TERM THERAPY WITH GABAPENTIN (GBP NEURONTIN) - 5-YEAR EXPERIENCE FROM A US OPEN-LABEL TRIAL
LEIDERMAN, DB
KOTO, EM
LAMOREAUX, LK
MCLEAN, MJ
EPILEPSIA, 1995, 36 : 345 - 345
[43] Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial
Ashina, Messoud
Goadsby, Peter J.
Reuter, Uwe
Silberstein, Stephen
Dodick, David W.
Xue, Fei
Zhang, Feng
Paiva da Silva Lima, Gabriel
Cheng, Sunfa
Mikol, Daniel D.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (05) : 1716 - 1725
[44] Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial
Petersenn, S.
Salgado, L. R.
Schopohl, J.
Portocarrero-Ortiz, L.
Arnaldi, G.
Lacroix, A.
Scaroni, C.
Ravichandran, S.
Kandra, A.
Biller, B. M. K.
ENDOCRINE, 2017, 57 (01) : 156 - 165
[45] Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial
Calvaruso, Giusi
Vitrano, Angela
Di Maggio, Rosario
Ballas, Samir
Steinberg, Martin H.
Rigano, Paolo
Sacco, Massimiliano
Telfer, Paul
Renda, Disma
Barone, Rita
Maggio, Aurelio
BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (04) : 265 - 271
[46] Long-Term Efficacy Of Dupilumab In Adults With Moderate-to-Severe Atopic Dermatitis: Results From A 5-Year Open-Label Extension Trial
Beck, Lisa
Bissonnette, Robert
Deleuran, Mette
Nakahara, Take-shi
Galus, Ryszard
Xiao, Jing
Avetisova, Elena
Du-bost-Brama, Ariane
Shabbir, Arsalan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
[47] Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease 5-Year Results From the PLATINUM Trial
Kelly, Christopher R.
Teirstein, Paul S.
Meredith, Ian T.
Farah, Bruno
Dubois, Christophe L.
Feldman, Robert L.
Dens, Joseph
Hagiwara, Nobuhisa
Rabinowitz, Abram
Carrie, Didier
Pompili, Vincent
Bouchard, Alain
Saito, Shigeru
Allocco, Dominic J.
Dawkins, Keith D.
Stone, Gregg W.
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (23) : 2392 - 2400
[48] Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial
S. Petersenn
L. R. Salgado
J. Schopohl
L. Portocarrero-Ortiz
G. Arnaldi
A. Lacroix
C. Scaroni
S. Ravichandran
A. Kandra
B. M. K. Biller
Endocrine, 2017, 57 : 156 - 165
[49] Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation Lessons From a 5-Year Follow-Up
Ouyang, Feifan
Tilz, Roland
Chun, Julian
Schmidt, Boris
Wissner, Erik
Zerm, Thomas
Neven, Kars
Koektuerk, Bulent
Konstantinidou, Melanie
Metzner, Andreas
Fuernkranz, Alexander
Kuck, Karl-Heinz
CIRCULATION, 2010, 122 (23) : 2368 - 2377
[50] Early and long-term results of lung volume reduction in patients with emphysema
Chihara, K
Nakajima, D
Yamashina, A
Nakai, M
Sahara, H
Tsuda, T
Kono, T
Osumi, A
Aoyama, A
Chen, F
Isowa, N
Iwakiri, S
CHEST, 2005, 128 (04) : 311S - 311S

← 1 2 3 4 5 →